What Do Allergy Shots Do? How They Retrain Your Immune System
Allergy shots fundamentally reprogram your immune system through a three-act process: the immune system stops overreacting to allergens as IgG4 blocking antibodies rise 10-100x above baseline and regulatory T cells expand. A 2007 Cochrane review found SCIT reduces symptom scores by 33% and medication use by 36% across 51 RCTs. Unlike antihistamines, these changes persist 3-12 years after treatment ends. This is the only disease-modifying treatment for IgE-mediated allergic disease.
7 peer-reviewed sources
Allergy shots reprogram your immune system over 3-5 years by shifting allergic Th2 responses toward regulatory T-cell tolerance, raising blocking antibodies that intercept allergens before they trigger histamine cascades. Benefits persist years after stopping.
The Three-Act Story of What Allergy Shots Actually Do
To understand what allergy shots DO, it helps to understand the problem they are solving. In allergic individuals, the immune system has made a fundamental error: it classifies harmless environmental proteins — grass pollen, dust mite particles, cat Fel d 1 — as dangerous pathogens. Every exposure triggers IgE antibodies to alert mast cells, which then release histamine, causing the familiar cascade of sneezing, itching, congestion, and watery eyes.
Allergy shots address this problem at its source. By introducing controlled microdoses of the same proteins that trigger your immune overreaction, SCIT gradually teaches the immune system to stand down — converting an allergic Th2 response into an active, regulated tolerance. This is not symptom suppression. It is a fundamental change in how your immune system categorizes these proteins.
The starting point for understanding which proteins your immune system has misfiled is specific allergy testing. Curex at-home allergy testing measures your IgE reactivity to 40+ environmental allergens through a simple finger-prick blood test, identifying the exact triggers your immune system needs to be retrained against.
The outcome of successful SCIT treatment is measurable: symptom scores drop by 33%, medication use falls by 36%, and these improvements persist for years after the last injection. In children with allergic rhinitis, SCIT also reduces the risk of developing asthma — evidence that the immune changes are systemic, not just local.
Allergy shots are the only treatment that changes the underlying immune error causing allergic disease. Antihistamines suppress symptoms; allergy shots eliminate the reason those symptoms occur in the first place.
The Three-Act Immune Transformation Allergy Shots Produce
The mechanism of allergy shots is a three-act transformation. Act 1 is the problem: an immune system that has learned to generate IgE antibodies against harmless allergen proteins, priming mast cells and basophils to release histamine on every exposure. Act 2 is the intervention: controlled subcutaneous allergen exposure that redirects immune signaling from Th2-driven allergy toward Treg-mediated active tolerance. Act 3 is the outcome: reduced IgE activity, rising IgG4 blocking antibodies, and a mast cell population that no longer degranulates in response to your specific allergens.
The Problem — Immune System Misidentification
Your immune system has learned to treat specific allergen proteins as threats, producing IgE antibodies that arm mast cells and basophils. When allergens bind to IgE-armed mast cells, they degranulate — releasing histamine, prostaglandins, and leukotrienes that cause allergic symptoms. This misfiling is the root cause of all IgE-mediated allergic disease.
The Intervention — Controlled Allergen Re-Exposure
Allergy shots introduce your specific allergen proteins subcutaneously at doses calibrated to stimulate immune tolerance without triggering a systemic allergic reaction. Starting at 1/1,000 to 1/10,000 of the maintenance dose, each injection builds on the last. Antigen-presenting cells in the subcutaneous tissue process these proteins and present them to T cells in regional lymph nodes under non-inflammatory conditions — the key difference from natural allergen exposure that perpetuates the allergic response.
The Change — IgG4 Blocking Antibodies and Tregs Rise
As injections continue, FOXP3+ regulatory T cells (Tregs) begin expanding within 2-4 weeks of treatment initiation — detectable in peripheral blood. IgG4 blocking antibodies rise 10-100x above baseline, competing with IgE for allergen binding at mast cell surfaces. When IgG4 intercepts the allergen before it reaches mast cell-bound IgE, no degranulation occurs. Basophil reactivity also decreases measurably during the build-up phase, meaning the cells that release histamine are increasingly hard to activate.
The Outcome — Lasting Disease Modification
After 3-5 years, the immune retraining becomes self-sustaining. Long-term IgE levels decline across the treatment course. Disease-modifying benefits persist 3-12 years after stopping — evidence that this is genuine immune reprogramming, not a treatment that wears off. SCIT also prevents new sensitizations to additional allergens and reduces asthma risk in children with allergic rhinitis.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
What the Evidence Shows About What Allergy Shots Accomplish
The efficacy of allergy shots is among the most thoroughly documented in allergy medicine. The landmark Cochrane review by Calderon et al. (2007) analyzed 51 randomized controlled trials involving 2,871 patients and found a pooled standardized mean difference (SMD) of -0.73 for symptom reduction and -0.57 for medication use reduction — both clinically and statistically significant. The number needed to treat (NNT) for symptom improvement is 3, meaning one in every three patients benefits meaningfully from treatment beyond what placebo produces. For patients ready to pursue these immune-retraining benefits — the Th2-to-Treg shift, the rising IgG4 blocking antibodies, the lasting tolerance documented above — Curex's At-Home Allergy Shot Kit delivers the identical SCIT protocol at home: a personalized allergen serum sterile-compounded to USP <797>, one weekly subcutaneous shot self-administered at home for $129/month, with the first injection and every dose change supervised live over Zoom by a board-certified allergist.
Success Rate by Duration
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youFrequently asked questions
What does allergy shots do to your immune system long-term?
Long-term, allergy shots fundamentally alter the immune system's response to your specific allergens. IgG4 blocking antibodies — which rise 10-100x during treatment — remain elevated for years after stopping, continuing to intercept allergens before they trigger mast cell degranulation. FOXP3+ regulatory T cells (Tregs) maintain a higher threshold of activation in response to allergen stimulation. Long-term IgE levels decline gradually across the treatment course. Durham et al. (NEJM, 1999) showed benefits persisting 3 years after stopping grass pollen SCIT; Eng et al. (Allergy, 2006) found durability up to 12 years in a separate cohort. These are genuine, lasting immune changes — not temporary suppression.
Do allergy shots reduce IgE levels?
Allergy shots do reduce specific IgE levels over time, though the relationship is complex. In the early phase of treatment, IgE levels may transiently rise as the immune system responds to allergen exposure. Over the full 3-5 year course, total and specific IgE levels generally decline as the immune phenotype shifts from Th2-driven (which promotes IgE synthesis) to Treg-mediated tolerance. However, IgE reduction is not the primary mechanism of symptom improvement — the more important early change is the rise in IgG4 blocking antibodies that compete with IgE for allergen binding at mast cell surfaces. Symptom improvement can occur even before IgE levels decline significantly.
Why are allergy shots better than antihistamines long-term?
Allergy shots address the root cause of allergic disease while antihistamines only suppress symptoms. Antihistamines block H1 receptors, preventing histamine from binding to tissues after mast cells have already degranulated — they do nothing to change why those mast cells fire in the first place. When you stop taking antihistamines, symptoms return immediately because the underlying immune error is unchanged. Allergy shots, by contrast, progressively reprogram the immune response so that allergens no longer trigger significant mast cell activation at all. Clinical evidence shows that this reprogramming persists 3-12 years after stopping treatment, compared to zero persistent benefit from antihistamines after discontinuation.
Can allergy shots prevent asthma from developing?
Clinical evidence suggests allergy shots can reduce the risk of asthma development in children with allergic rhinitis — one of the most compelling arguments for early treatment. The PAT (Preventive Allergy Treatment) study by Moller et al. (JACI, 2002) followed children aged 6-14 with allergic rhinitis who received SCIT for 3 years. At 7-year follow-up, children who received SCIT had significantly lower rates of asthma development than controls, with an odds ratio of 2.52 favoring the SCIT group. This preventive effect reflects the systemic nature of the immune changes SCIT produces — tolerance that extends beyond the treated allergens and reduces overall atopic disease burden.
How do allergy shots differ from taking a steroid shot for allergies?
Allergy shots (immunotherapy) and steroid shots (such as Kenalog / triamcinolone) are completely different treatments with different mechanisms, purposes, and risk profiles. A steroid shot provides 3-6 weeks of broad anti-inflammatory relief by suppressing the entire immune response — it temporarily blocks allergic symptoms across all triggers but provides no disease modification and carries steroid-related risks including adrenal suppression, bone density loss, and glucose elevation with repeated use. Allergy shots, by contrast, target your specific allergens and progressively train your immune system to tolerate them — the benefit grows over time rather than wearing off. AAAAI and ACAAI discourage routine use of corticosteroid injections for allergic rhinitis management.
Do allergy shots also work for food allergies?
Standard subcutaneous allergy shots (SCIT) are not used for food allergies because the systemic reaction risk is too high when food allergen extracts are injected. The appropriate immunotherapy form for food allergy is oral immunotherapy (OIT), not SCIT. The FDA approved Palforzia (peanut OIT) in 2020 for peanut-allergic patients aged 4-17. SCIT is effective and FDA-approved for inhalant allergens (pollen, dust mites, mold, pet dander) and stinging insect venom allergy. If you have both inhalant and food allergies, your allergist may recommend SCIT for the inhalant components while separately evaluating food allergy management options.
What changes can patients feel after starting allergy shots?
Most patients begin to notice subjective symptom improvement — less frequent sneezing, reduced nasal congestion, milder eye symptoms — within 3 to 6 months of starting allergy shots, typically as doses approach the maintenance level. The initial improvement is often subtle: needing antihistamines on fewer days per week, or getting through pollen season with milder symptoms than previous years. By 12-18 months, many patients report they can reduce their rescue medication use significantly. Some patients notice improved sleep quality as nasal congestion decreases. The most dramatic improvements are often seen in patients with severe pre-treatment symptoms, where the contrast with their new baseline is most apparent.
Does getting allergy shots hurt?
Allergy shots are administered with a small 25-27 gauge needle — thinner and shorter than most vaccine needles — into the subcutaneous tissue of the upper arm. Most patients describe the sensation as a brief, mild pinch, similar to a small vaccine injection. The injection volume is very small (0.05-0.5mL depending on treatment phase), so the procedure takes only a few seconds. Local redness, mild swelling, or itching at the injection site is common and normal — occurring in 30-80% of patients — and typically resolves within 30-60 minutes. If you have a history of significant local reactions, your allergist may recommend pre-medicating with an antihistamine before your appointment to reduce discomfort.
Related Articles
How Long Do Allergy Shots Take? Trial vs Reality | Curex
How long do allergy shots take to work? Trials show 12-month benefit, but only 23% complete 3 years. Real-world vs clinical data guide.
Read moreAllergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreWhat Is Allergy Shots? Quick Definition and How It Works
What is allergy shots? SCIT trains your immune system to tolerate allergens over 3-5 years. 85-90% of patients see significant improvement.
Read moreAllergy Shot Side Effects: Per-Injection Timeline | Curex
What happens after each allergy shot? A minute-by-minute timeline from the 30-min wait to 48-hour local reactions, with safety thresholds and real data.
Read moreAllergy Immunotherapy Guide: All Options Compared | Curex
Allergy immunotherapy covers shots, tablets, drops, and OIT. Compare SCIT vs SLIT on efficacy, safety, cost, and FDA status to choose the right route.
Read moreAllergy Shots: Complete SCIT Guide for Patients | Curex
Allergy shots (SCIT) reduce symptoms by 33-85% over 3-5 years. Learn how they work, what they cost, and who qualifies for this disease-modifying treatment.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.